ZARS Pharma

Welcome to ZARS Pharma

ZARS Pharma is a specialty pharmaceutical company focused on the development and commercialization of topically administered drugs using our proprietary drug delivery technologies, primarily in the area of pain management.

News ()

Previous Next

04/19/07
ZARS Announces First European Marketing Approval and License Agreement with EUSA Pharma for Rapydan®
03/10/08
ZARS Pharma, Inc. announced today the completion of an agreement providing Galderma Pharma S.A. the exclusive promotion and distribution rights for all markets outside the United States and Canada for Pliaglis™
07/25/07
ZARS, Inc., announced today that it commenced the first of two Phase 3 clinical trials of ThermoProfen™ in patients with mild to moderate osteoarthritis (OA) of the knee on June 26, 2007.

Pliaglis™

Pliaglis™

Synera™